Vaccination News Home Page Scandals subscribe Vaccination NewsLetter
http://a257.g.akamaitech.net/7/257/2422/14mar20010800/edocket.access.gpo.gov/2003/03-11877.htm
[Federal Register: May 13, 2003 (Volume 68, Number 92)]
[Notices]
[Page 25615-25616]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13my03-99]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee, Subcommittee on Future
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on
Vaccine Safety and Communication: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee and
subcommittee meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-2:15 p.m., June 3, 2003; 8:30 a.m.-3
p.m., June 4, 2003.
Place: Hubert H. Humphrey Building, Room 705A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m.
and 1 p.m. Entrance to the meeting at other times during the day
cannot be assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters to be Discussed: Agenda items will include: a report
from the National Vaccine Program Office (NVPO); an update on the
Smallpox Vaccination Program; a report from the Acting Assistant
Secretary for Health; an update on vaccine supply issues; a report
from the polio vaccine stockpile workgroup; a report on the
Institute of Medicine (IOM) Vaccine Safety Review Committee; a
report from the IOM on their review of the Smallpox Vaccination
Program; a report from the Influenza Immunization Summit; an update
on pandemic influenza planning; a report from the Immunization
Coverage Subcommittee, the Future Vaccines Subcommittee, and the
Vaccine Safety and Communication Subcommittee; a discussion of
compensation for vaccine administration; a discussion on Enhancing
Public Participation in Immunization Decision-Making; a report from
the Workgroup on Public Health Options for Implementing Immunization
Recommendations; a report from the Polio Laboratory Containment
Workgroup; a discussion of monitoring anthrax vaccine adverse events
using the Department of Defense Medical Surveillance System; reports
from the Advisory Commission on Childhood Vaccines/Division of
Vaccine Injury Compensation, the Vaccine Related Biological Products
Advisory Committee/Food and Drug Administration, and the Advisory
Committee on Immunization Practices/National Immunization Program/
National Center for Infectious Diseases.
Name: Subcommittee on Future Vaccines.
Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee develops policy options and guides
national activities that lead to accelerated development, licensure,
and the best use of new vaccines in the simplest possible
immunization schedules.
Matters to be Discussed: Agenda items will include an update on
the proposed pneumococcal meeting; an update on the newborn
vaccination meeting; CMV status report; and a presentation on Group
A Steptococcus vaccines.
Name: Subcommittee on Immunization Coverage.
Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
Place: Hubert H. Humphrey Building, Room 705A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee identifies and proposes solutions
that provide a multifaceted and holistic approach to
[[Page 25616]]
reducing barriers that result in low immunization coverage for
children.
Matters to be Discussed: Agenda items will include an update on
publication of the newly revised Adult and Pediatric Immunization
Standards; a discussion of adolescent immunization; Immunization
Registries--Updates on the use of VFC funds for registry development
standards of excellence; PCV7 update on impact of shortage on
coverage and active bacterial core surveillance; a discussion of the
draft report from the Workgroup on Public Health Options for
Implementing Immunization Recommendations; updates on pneumococcal
and influenza coverage; and a review of data on the burden of
pneumococcal disease.
Name: Subcommittee on Vaccine Safety and Communication.
Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee reviews issues relevant to vaccine
safety and adverse reactions to vaccines.
Matters to be Discussed: Next Steps in Risk Communication:
Reviews of IOM Immunization Safety Review Committee Recommendations,
and of NVPO Workshop Recommendations; a discussion of the influenza
communications programs; a discussion of next topics for the IOM
Safety Review Committee; a review of the National Immunization
Program Website; and, an update on thimerosal-related litigation.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gloria Sagar, Committee
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77,
Chamblee, Georgia 30341, telephone 770/488-2040.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: May 7, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 03-11877 Filed 5-12-03; 8:45 am]
BILLING CODE 4163-18-P
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.